Smart oxygen device fails to prove benefit in small COPD trial

NCT ID NCT03835741

First seen Nov 01, 2025 · Last updated Jun 14, 2026 · Updated 35 times

Summary

This study tested whether an automated oxygen adjustment device (FreeO2) could reduce how long people with a COPD flare-up stay in the hospital, compared to manual oxygen adjustments. Only 17 people took part before the study was stopped early. The goal was to see if the device could help patients get the right amount of oxygen without needing constant manual changes.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HYPOXEMIA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Locations

  • Institut Universitaire de Cardiologie et de Pneumologie de Québec

    Québec, Quebec, G1V4G5, Canada

Conditions

Explore the condition pages connected to this study.